ICD-10-CM 2027 diagnosis code
C69.8Malignant neoplasm of overlapping sites of eye and adnexa
C69.8 is a header code, so it can't be reported by itself. Choose one of the 3 more specific codes beneath it.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About C69.8
C69.8 is the ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of eye and adnexa. It belongs to category C69 (malignant neoplasm of eye and adnexa), block C69-C72 (malignant neoplasms of eye, brain and other parts of central nervous system) and chapter 2 (neoplasms). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.
Within C69 (malignant neoplasm of eye and adnexa), C69.8 is specifically for malignant neoplasm of overlapping sites of eye and adnexa. Related codes cover conjunctiva (C69.0), cornea (C69.1), retina (C69.2), choroid (C69.3), ciliary body (C69.4), lacrimal gland and duct (C69.5), orbit (C69.6) and unspecified site of eye (C69.9).
To report this condition, pick the subcode that matches the documentation: C69.80 (adnexa), C69.81 (adnexa) and C69.82 (adnexa).
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Specific codes under C69.8
Notes that apply from higher levels
Instructions written at a parent level also apply to C69.8.
Broader instructions also apply from Chapter 2: Neoplasms.
Table of Drugs & Neoplasms entries
- Neoplasm, neoplastic › eye NEC › overlapping sites — Malignant Primary
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about C69.8
Is C69.8 billable?
- No. C69.8 is a header code. Report one of its more specific subcodes instead.